Family Medicine Doctors in Ecru, MS Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Dr. Crystal Lane Tate, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Main St, Ecru, MS 38841 Phone: 662-489-5609 Fax: 662-489-3814 |
News Archive
Meditation shows improved outcomes in patients with medically unexplained symptoms
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
X-ray beams could kick start genes into fighting cancer
X-ray beams could kick start genes into fighting cancer as an exciting new way of targeting therapy against the disease, according to new research in the Journal of Gene Medicine.
Longer looks at Supreme Court battle: Interactions of justices are key to decision; Creating 'Zombie Obamacare'
Welcome to the world of the law, Supreme Court edition, where after Tuesday's remarkable hearing the five conservative justices appeared eager, or at least willing, to defend an unworkable status quo that rewards people who choose to blow off health insurance coverage knowing that they will be treated anyway if they show up ill at a hospital.
AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds
Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.
ITS commences treatment in synthetic universal influenza vaccine Phase I trial
Immune Targeting Systems (ITS) Limited, one of the leading developers of synthetic vaccines for mutating viruses, today announced the first patient has been treated in its Phase-I trial with its synthetic universal influenza vaccine (FP-01). Commencement of trials follows receipt of UK Regulatory Authority (MHRA) approval. Over the same period the company brought in £500,000 new investment from Esperante Ventures (UK).
› Verified 1 days ago